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Abstract
The identiﬁcation of Zygomycetes and diagnosis of zygomycosis are notoriously difﬁcult. However, there have been recent advances, particularly
in the availability and evaluation of new molecular approaches. Two main issues are of importance: the identiﬁcation to species level of a strain
isolated in culture, and the identiﬁcation of a zygomycete in tissues. By using several molecular targets and by increasing the number of available
DNA sequences in international databases, several studies have shown that accurate molecular identiﬁcation of Zygomycetes to species level is
feasible. The internal transcribed spacer (ITS) region may be used as a ﬁrst-line molecular target for the identiﬁcation of Zygomycetes in pure
culture. However, cultures from infected tissues are often negative and the different Zygomycetes share similar morphology according to histo-
pathology. Furthermore, differentiation of a zygomycete from another hyalohyphomycete can sometimes be difﬁcult in histopathology. Thus,
alternative methods for the diagnosis of zygomycosis and for species identiﬁcation directly from tissues are needed. For this purpose, molecular
methods have been recently evaluated, both on unﬁxed fresh/frozen material and on formalin-ﬁxed, parafﬁn-embedded biopsies. This review
discusses the molecular approaches currently available for the identiﬁcation of Zygomycetes and the diagnosis of zygomycosis.
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Introduction
Zygomycetes belong to a large group of fungi that comprise
two orders of medical interest, the Entomophthorales and the
Mucorales. Mucorales are the most frequent; c. 20 species in
c. 10 genera have been reported to cause human zygomycosis
[1,2]. Rhizopus spp., Mucor spp., Rhizomucor spp. and Mycocladus
corymbifer (formerly Absidia corymbifera), as well as other spe-
cies such as Cunninghamella bertholletiae, Apophysomyces elegans
and Saksenaea vasiformis, are responsible for infections [3].
Over the past years, molecular data have contributed to a
better understanding of the taxonomy and phylogeny of
Zygomycetes. In particular, several DNA targets, including
ribosomal DNA genes (18S, 28S, internal transcribed spacer
(ITS)) [4–8] and genes coding for actin [6,8,9], elongation
factor 1-a [5,8,9] or lactate dehydrogenase [10], have been
used for phylogenetic species recognition. Other studies have
evaluated several molecular targets for the identiﬁcation of
the pathogenic Zygomycetes to species level [4,11–19].
Indeed, identiﬁcation of the isolates responsible for infection
will enhance our knowledge of the epidemiology of the
disease and may be important in the future therapeutic
management of patients when more antifungal drugs become
available.
In the microbiology laboratory, there are currently two
important issues. The ﬁrst is the identiﬁcation to species
level of a strain isolated in culture, and the second is the
diagnosis of zygomycosis and identiﬁcation of a Zygomycetes
directly in tissues.
Identiﬁcation of Zygomycetes from Culture
The classical method of identiﬁcation of Zygomycetes
involves phenotypic identiﬁcation based mainly on morpho-
logical characteristics. However, identiﬁcation by morphology
is difﬁcult and time-consuming and sometimes needs the
expertise of a reference laboratory. Moreover, some species,
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such as A. elegans and S. vasiformis, fail to sporulate on stan-
dard media and their identiﬁcation relies on more specialized
tests [20]. The difﬁculty of phenotypic identiﬁcation of Zygo-
mycetes has been highlighted recently [19]; in a comparison
between morphological and molecular identiﬁcation of 27
clinical isolates, standard mycological identiﬁcation proved
erroneous in more than 20% of cases. In this context, molec-
ular approaches, particularly sequence-based identiﬁcation,
are of interest.
For reliable molecular identiﬁcation (DNA barcoding),
both an informative DNA target and a comprehensive and
accurate sequence database should be available [21]. Ideally,
the DNA target should work for all the species in the group
of interest and sequences should have a low intra-speciﬁc
variability (i.e. the differences should be as low as possible
among isolates within a given species) and a high inter-
speciﬁc variability (i.e. the differences should be as high as
possible among isolates belonging to different species). A
validated sequence database is also of prime importance. It
has been shown that an incomplete sequence library can lead
to the misidentiﬁcation of Zygomycetes isolates (including
the most frequently pathogenic species) in c. 50% of cases
[12].
The available loci for species identiﬁcation are summarized
in Table 1. Most studies have evaluated ribosomal targets
(18S, 28S and ITS). More recently, other DNA targets, such as
the high-afﬁnity iron permease 1 gene FTR1 or cytochrome b,
have been used. In one study, both the 18S and the D1–D2
domains of the 28S from 42 Zygomycetes isolates (comprising
all the human pathogenic species) were ampliﬁed by polymer-
ase chain reaction (PCR) and sequenced [4]. The 18S
sequences were highly conserved, but the 28S sequences were
more variable among species. Based on this variability, it was
possible to design speciﬁc primers that could be used for the
identiﬁcation of 13 species. A different approach, combining
PCR ampliﬁcation of a part of the 18S rDNA followed by
restriction enzyme digestion, obtained speciﬁc patterns, allow-
ing for identiﬁcation to species level [11].
Evaluation of intra- and inter-species variability of ITS
sequences has also been reported recently [13]. The whole
ITS1–5.8S–ITS2 region from 54 isolates of Zygomycetes
belonging to 16 species was ampliﬁed with universal fungal
primers and sequenced. In a given species, the variability
among isolates was very low, at <2%. By contrast, distances
between ITS sequences among species were very large.
Sequence variability was even high among species belonging
to the same genus. For example, Rhizopus oryzae and Rhizo-
pus microsporus shared <70% sequence similarity. Although
there were some exceptions of closely related species that
were not resolved by ITS sequencing, these results showed
that sequencing of the ITS region is a reliable method for
the accurate identiﬁcation of most Zygomycetes to species
level. Other studies (Table 1) have also evaluated the utility
of ITS sequencing for the identiﬁcation of speciﬁc species or
genera such as A. elegans [16] and Rhizopus spp. [15]. Finally,
ITS sequencing has been successfully employed for identiﬁca-
tion to species level of Zygomycetes in culture in individual
case reports [22, 23].
More recently, a fragment of the FTR1 gene was used to
generate a sequence dataset for the identiﬁcation of some
Zygomycetes [17]. Although it was possible to differentiate
most of the Rhizopus species, this locus was not useful for
resolving some Rhizomucor and Mucor species. The cyto-
chrome b gene has also been evaluated in a real-time PCR
format for the identiﬁcation of several genera belonging to
the Zygomycetes [18].
Based on published results and expert opinions, guidelines
for fungal identiﬁcation by DNA target sequencing have been
published very recently by the CLSI [24]. For the identiﬁ-
cation of Zygomycetes, the ITS has been proposed as a
valuable target for resolution to genus and usually to species
level (e.g. ﬁve species of Rhizopus can be distinguished). The
D1/D2 region of the 28S, as an alternative target, may
provide resolution to species level. Similarly, the Inter-
national Society of Human and Animal Mycology (ISHAM)
Working Group on Fungal Molecular Identiﬁcation has
proposed the use of ITS sequencing as a ﬁrst-line strategy
for Zygomycetes identiﬁcation (ISHAM, unpublished data,
2008).
Overall, the evaluation of different molecular targets and
the increasing number of available DNA sequences in inter-
national databases allow the accurate molecular identiﬁcation
of Zygomycetes to species level in pure culture.
TABLE 1. Available loci and techniques used for species
identiﬁcation of Zygomycetes from cultures
Species
Target
region Method References
Several species 28S PCR + sequencing Voigt et al. 1999 [4]
Several species 18S PCR + RFLP Machouart et al. 2006 [11]
Several species 28S MicroSeqa Hall et al. 2004 [12]
Several species ITS PCR + sequencing Schwarz et al. 2006 [13]
Several species Cyt b Real-time PCR Hata et al. 2008 [18]
Several species ITS PCR + sequencing Kontoyiannis et al. 2005 [19]
Rhizopus species ITS Multiplex PCR Nagao et al. 2005 [15]
Rhizopus oryzae ITS PCR + sequencing Abe et al. 2003 [14]
Rhizopus species FTR1 PCR + sequencing Nyilasi et al. 2008 [17]
Apophysomyces
elegans
ITS PCR + RFLP Chakrabarti et al. 2003 [16]
aD2 large subunit ribosomal DNA sequencing kit.
28S, large subunit ribosomal DNA; 18S, small subunit ribosomal DNA; ITS, ribo-
somal DNA internal transcribed spacer; Cyt b, cytochrome b gene; FTR1, high-
afﬁnity iron permease 1 gene; PCR, polymerase chain reaction; RFLP, restricted
fragment length polymorphism.
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Identiﬁcation of Zygomycetes in Tissue
Samples
Tissue samples obtained from patients with zygomycosis are
often culture-negative. By histopathology or direct examina-
tion, Zygomycetes appear as irregular, large, non-septate
hyphae with right-angle branching. However, it is not possible
to make more precise identiﬁcation to species, or even to
genus, level based on morphology in tissues. Furthermore,
when there are few fungal elements or when the fungus is
altered, differentiation between a zygomycete and another
hyalohyphomycete may be difﬁcult by histopathology or direct
examination. Thus, new methods for the diagnosis of zygomy-
cosis and for species identiﬁcation directly from tissues must
be developed. For this reason, molecular methods have been
recently evaluated both on unﬁxed fresh/frozen tissue samples
and on formalin-ﬁxed, parafﬁn-embedded biopsies.
Fresh/frozen tissue samples
Overall, reliable identiﬁcations have been obtained from
fresh or frozen tissue samples (Table 2). In an experimental
model of zygomycosis in mice, the molecular identiﬁcation of
six different species of Zygomycetes (belonging to Rhizopus,
Mycocladus, Mucor or Rhizomucor) was achieved from frozen
tissue samples of kidney and brain by PCR ampliﬁcation with
pan-fungal primers followed by direct sequencing of the ITS
region [13]. Good sensitivity and speciﬁcity were obtained,
with positive PCR results and correct identiﬁcation in all
samples with a positive direct examination. A similar
approach was used successfully in seven tissue samples from
three patients with histology and culture-proven zygomycosis
[25]. Molecular identiﬁcation, using various techniques and
targets, has also been used in selected case reports to iden-
tify Zygomycetes such as C. bertholletiae, Rhizomucor pusillus,
R. microsporus, M. corymbifer and S. vasiformis in tissue sam-
ples from patients with either pulmonary, rhino-cerebral or
cutaneous zygomycosis [11, 22, 26–28].
Formalin-ﬁxed, parafﬁn-embedded tissue samples
Ampliﬁcation by PCR of fungal DNA from formalin-ﬁxed tis-
sues is more challenging than from fresh or frozen unﬁxed
samples because of the possible degradation of DNA during
ﬁxation. Table 3 shows examples of molecular methods and
targets used for species identiﬁcation of Zygomycetes in for-
malin-ﬁxed, parafﬁn-embedded tissues. In a recent European
multicentre study, the identiﬁcation of different Zygomycetes
to species level was evaluated in parafﬁn-embedded tissues
obtained from experimentally infected mice [29]. Brain and
kidney samples (all positive by histology) from mice infected
with R. oryzae, R. microsporus, R. pusillus or M. corymbifer were
subjected to ITS1 sequencing after PCR with pan-fungal
primers. Reliable identiﬁcation was possible and good inter-
laboratory reproducibility was obtained, although the sensitiv-
ity of the technique was not optimal. A similar approach was
recently evaluated on formalin-ﬁxed, parafﬁn-embedded
samples obtained from patients with proven fungal infections
[25]. The molecular diagnosis was negative in four of nine his-
tologically positive samples, but, in the case of positive PCR,
identiﬁcation to the species was possible, which indicates an
important advantage over histopathology. A different tech-
nique, using a semi-nested PCR, speciﬁc for Zygomycetes and
targeting the 28S, has been tested on a large number of
TABLE 2. Examples of molecular methods and targets used for species identiﬁcation of Zygomycetes in fresh or frozen tissues
Method (target) Infection or sample Species References
PCR + sequencing (ITS) Disseminateda Several species (n = 6) Schwarz et al. 2006 [13]
PCR + sequencing (ITS) Sinus, buttock Rhizopus oryzae, Apophysomyces elegans Lau et al. 2006 [25]
PCR + sequencing (28S) Pulmonary Cunninghamella bertholletiae Kobayashi et al. 2004 [27]
PCR + RFLP (18S) Cutaneous Rhizopus microsporus Larche et al. 2005 [28]
PCR + RFLP (18S) Pulmonary, cutaneous Mycocladus corymbifer, R. microsporus Machouart et al. 2006 [11]
PCR + sequencing (ITS) Sino-orbital Rhizomucor pusillus Iwen et al. 2005 [22]
PCR + sequencing (ITS) Cutaneous Saksenaea vasiformis Lechevalier et al. 2008 [26]
Real-time PCR (Cyt b) Sinus A. elegans Hata et al. 2008 [18]
aExperimental data obtained in a murine model of disseminated zygomycosis.
18S, small subunit ribosomal DNA; ITS, ribosomal DNA internal transcribed spacer; Cyt b, cytochrome b gene; PCR, polymerase chain reaction; RFLP, restricted fragment
length polymorphism.
TABLE 3. Examples of molecular methods and targets used
for species identiﬁcation of Zygomycetes in formalin-ﬁxed,
parafﬁn-embedded tissues
Method Target References
PCR + sequencing ITS1a Dannaoui et al. 2007 [29]
In situ hybridization 18S Hayden et al. 2002 [33]
PCR + sequencing ITS Lau et al. 2006 [25]
Semi-nested PCR 18S Bialek et al. 2005;
Rickerts et al. 2006, 2007 [30–32]
Real-time PCR Cyt b Hata et al. 2008 [18]
aExperimental data obtained in a murine model of disseminated zygomycosis.
18S, small subunit ribosomal DNA; ITS, ribosomal DNA internal transcribed
spacer; Cyt b, cytochrome b gene; PCR, polymerase chain reaction.
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clinical samples [30–32] and has shown promising results. In
one study, PCR was positive in all seven samples with histol-
ogy indicative of zygomycosis [31]. In another study of 23
samples with positive histology, PCR was positive for 14
samples and negative for the other nine samples [32]. In a
prospective multicentre study, this semi-nested PCR assay
was compared with histopathology and culture results for 56
respiratory tract biopsy samples obtained from patients with
suspected fungal infection [30]. For all the six samples with
histology results indicative of zygomycosis, PCR was positive,
whereas culture was positive in only two of these samples.
More recently, by using a real-time PCR format, Hata et al.
were able to detect Zygomycetes in 35 of 62 formalin-ﬁxed,
parafﬁn-embedded tissue samples positive by histopathology,
resulting in a sensitivity of 56% [18]. In situ hybridization with
pan-fungal and Zygomycetes-speciﬁc probes has also been
used in culture-proven cases of zygomycosis and has shown
good sensitivity and speciﬁcity [33].
Conclusions
In summary, new molecular tools are available for the identiﬁ-
cation of Zygomycetes in culture and in tissues. These tech-
niques may be more rapid and more reliable than standard
mycological identiﬁcation. Further studies are needed to
achieve better standardization of techniques and to improve
sensitivity for identiﬁcation in tissues.
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